Showing posts with label food and drug administration. Show all posts
Showing posts with label food and drug administration. Show all posts

Thursday, September 13, 2012

South Florida Man Sentenced to 120 Months in Prison in Drug Diversion Scheme



A South Florida man, William D. Rodriguez, has been sentenced to serve 120 months in prison in connection with a multi-million dollar prescription drug diversion and money-laundering scheme, the Justice Department announced today.   U.S. Judge Donald L. Graham of the Southern District of Florida also ordered that Rodriguez serve two years of supervised release after completion of his prison sentence.

 In June, Rodriguez pleaded guilty to conspiring with Altec Medical Inc. to defraud the U.S. Food and Drug Administration (FDA) in a scheme involving the resale of prescription drugs that had been diverted from lawful channels of distribution and resold to Altec by two companies controlled by Rodriguez.   Rodriguez also pleaded guilty to a separate conspiracy charge involving the laundering of proceeds of the diversion scheme.

“Drug diversion” refers to various ways in which prescription drugs are removed from lawful channels of distribution and then reintroduced into the marketplace for sale to consumers.  

 In a document submitted to the court at the time of his guilty plea, Rodriguez admitted that all of the drugs sold to Altec had been obtained from unlicensed, illegal drug distributors.   Rodriguez advised the court that the drugs were often obtained from street-level transactions in Miami, including those where individuals sold their medications for money.   In other instances, Rodriguez told the court that the drugs had been obtained from cargo thefts.  

 Rodriguez further admitted the conspirators created drug “pedigrees” that falsely said that the drugs had been obtained from legitimate sources, such as drug manufacturers or their authorized distributors.   Pedigrees are records of wholesale drug transactions and must reflect all prior sales or distributions of the drugs.   Rodriguez also admitted to conspiring to launder proceeds of the diversion scheme by cashing numerous checks over $10,000.   On Aug. 20, 2012, the court ordered Rodriguez to forfeit $55 million, representing the proceeds of the scheme.  

“Drug diversion is a serious crime that puts consumers at risk,” noted Stuart F. Delery, Acting Assistant Attorney General for the Justice Department’s Civil Division.   “Drugs diverted from the lawful channels of distribution may not have been properly handled and stored, which means they could have been contaminated, had their mechanisms of action altered, or they could be expired.  Drug Diversion undermines the safety and effectiveness of our prescription drug system, and we will continue to prosecute those who engage in it.”

The Justice Department advises consumers who have concerns about a drug to check the lot numbers on the manufacturer’s web site to see if there are any warnings about it.   Use of diverted drugs can cause unpredictable adverse side effects and may fail to treat the condition for which a consumer is taking the drugs.

 On Aug. 10, 2012, Altec pleaded guilty to the diversion scheme, was fined $2 million, and was ordered to forfeit $1 million.  

In April, Eduardo Torres, Rodriguez’s co-conspirator, pleaded guilty to the crime of providing a false drug pedigree.   He is scheduled to be sentenced on Sept. 19, 2012.

 The cases involving Rodriguez, Altec and Torres were investigated by the FDA’s Office of Criminal Investigations.   The cases were prosecuted by Assistant U.S. Attorney Jon M. Juenger of the U.S. Attorney’s Office for the Southern District of Florida, and David A. Frank of the Justice Department’s Consumer Protection Branch.   Additional assistance was provided by Joshua Eizen of the FDA’s Office of Chief Counsel for Enforcement.

Wednesday, September 12, 2012

Radiology Technician Sentenced to 30 Years for Product Tampering



JACKSONVILLE, FL—U.S. District Judge Marcia Morales Howard yesterday sentenced Steven Beumel (49, Jacksonville) to 30 years in federal prison for one count of tampering with a consumer product resulting in death, four counts of tampering with a consumer product resulting in serious bodily injury, and five counts of stealing Fentanyl by deception.

Beumel pleaded guilty to the charges on May 11, 2012.

According to court documents, Beumel was a radiology technician at Memorial Hospital from May 1992 through October 2004. He worked as a radiology technician at Mayo Clinic from October 2004 through August 2010. Beumel admitted that he stole syringes of Fentanyl during patients’ procedures and replaced them with syringes of saline contaminated with hepatitis C. Beumel’s tampering occurred from 2006 through 2008 at the Mayo Clinic’s Interventional Radiology Unit.

Epidemiologists from Mayo Clinic, the Florida Department of Health, and the CDC worked for more than three years to solve the hepatitis C outbreak at the Mayo Clinic. It was eventually linked to Beumel. Mayo Clinic immediately fired Beumel and reported his actions to law enforcement. The clinic tested thousands of patients who were potentially put at risk by Beumel’s actions. Two patients from that testing effort were linked to Beumel.

This case was investigated by the Federal Bureau of Investigation, the Food and Drug Administration, the Florida Department of Financial Services, and the Jacksonville Sheriff’s Office Homicide Unit. It was prosecuted by Assistant United States Attorney Frank Talbot.

Tuesday, September 11, 2012

Convictions Entered in Two Separate Texas Cases Involving Stem Cells



HOUSTON—Francisco Morales, 52, of Brownsville, Texas, and Illinois resident Lawrence Stowe, 59, have entered guilty pleas in a conspiracy to introduce misbranded and unapproved new drugs into interstate commerce, United States Attorney Kenneth Magidson announced today along with Patrick J. Holland, special agent in charge of the Food and Drug Administration (FDA)-Office of Criminal Investigations. Stowe and Morales both falsely represented they were licensed to practice medicine and that they each operated a medical clinics in Brownsville.

Just moments ago, Stowe admitted that beginning in January 2006, he utilized several businesses, Stowe BioTherapy Inc. and The Stowe Foundation, to advertise and promote a medical treatment protocol for the treatment of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease; multiple sclerosis (MS); Parkinson’s Disease; and other neurological diseases. This treatment protocol, which was named “Applied Biologics,” consisted of supplements, vaccines, patient-specific transfer factors, and, ultimately, stem cell therapy. Stowe falsely represented to patients that this treatment protocol had been reviewed by all levels of the FDA and was effective in the treatment of ALS, MS, and Parkinson’s. There is currently no cure for these diseases.

“These pleas are a victory for the American public, in demonstrating the FDA’s commitment to investigating cases of individuals and businesses that prey on the sick and vulnerable with phony medical treatments,” said Holland. “The FDA will continue to aggressively pursue perpetrators of such acts and ensure that they are punished to the full extent of the law.”

Stowe entered a plea of guilty today to conspiring with Morales and others to introduce supplements, vaccines, and stem cells that were not approved by the FDA, as well as introducing a misbranded and unapproved new drug called Immune Factor G-40 into interstate commerce, which had not been reviewed or approved by the FDA for human use.

Stowe further admitted that one of the unapproved drug products was a product called patient-specific transfer factors. In order to produce this product, he obtained the services of a pathologist in Bryan/College Station, Texas. He then directed patients to send samples of their blood to the pathologist for the purpose of growing bacteria that would later be used to create the patient-specific transfer factors. Stowe hired a laboratory in South Carolina to receive the bacteria, which was then fed to chickens. The eggs produced by these chickens were later freeze-dried, and the powder from the eggs was placed in capsules and sold to patients. Stowe admitted he knew the manufacturing process and the product itself were not approved by the FDA for that treatment of human diseases.

In January 2010, a person diagnosed with ALS had contacted Stowe about his treatment protocol. Stowe informed this person he would benefit from the treatment protocol and falsely stated it had been reviewed by all levels of the FDA. As a result, Stowe was paid $47,000 for drug products not approved for the treatment of any human disease.

On September 5, 2012, Morales was also convicted in this case. He admitted he sold an unapproved drug product to Stowe called SF 1019 knowing Stowe would sell this product to patients. Morales falsely represented to the public that he had extensive training and experience regarding stem cells and stem cell therapy, when his exposure was actually limited to attending seminars and reading materials published by researchers.

In June 2006, he received $8,300 from a couple to perform an unapproved stem cell procedure involving stem cells on their minor son who had experienced neurological problems after a near-drowning incident. Prior to performing the procedure, Morales falsely represented that the stem cell procedure would be beneficial to combat the child’s medical condition. He also falsely represented to two other patients that he obtained stem cells from private universities and had treated more than 1,000 patients using stem cells with only positive results.

Today, Morales also pleaded guilty in a second case for introducing stem cells extracted from umbilical cords into interstate commerce and introducing an unapproved new drug into interstate commerce.

Beginning in January 2007, he purchased stem cells from a company called Caledonia Consulting, located in Mt. Pleasant, South Carolina. After acquiring stem cells from Caledonia, he would travel to Mexico and perform stem cell procedures, knowing the FDA had not approved the use of stem cells to treat human diseases. Morales further admitted that in April 2009, he began purchasing vials containing stem cells from a company called Global Laboratories.

Morales was charged in this case along with Alberto Ramon, 50, of Del Rio, Texas, and Vincent Dammai, 42, of Mount Pleasant, South Carolina, who are set for trial on November 26, 2012. They are presumed innocent unless convicted though due process of law.

Morales faces up to five years in prison and a $250,00 fine for each of the two conspiracy convictions, as well as up to three years for introduction of an approved drug into interstate commerce. Stowe faces the same five-year sentence and $250,000 fine for one conspiracy conviction and up to three years and additional fines for each conviction of introduction of a misbranded drug and introduction of an unapproved drug into interstate commerce.

The cases were investigated by the FDA and the FBI, with assistance from Internal Revenue Service-Criminal Investigation. Assistant United States Attorneys Samuel Louis and Cedric Joubert prosecuted the case, with the assistance of Carol Wallack with the Department of Justice Civil Division’s Consumer Protection Branch.

Tuesday, August 28, 2012

Former Owner of Daytona Beach Clinic Pleads Guilty to Fraud, Conspiracy, and Money Laundering


ORLANDO, FL—United States Attorney Robert E. O’Neill announces that Joseph Wagner (62, Daytona Beach) today pleaded guilty to health care fraud, conspiracy to illegally distribute prescription drugs, and money laundering. Wagner faces a maximum penalty of 30 years in federal prison. He was indicted on June 13, 2012.

According to the plea agreement, Wagner was a licensed chiropractor and owner of Wagner Chiropractic and Acupuncture Clinic (WCAC) in Volusia County, Florida. He operated WCAC as a facility that purported to provide chiropractic and other medical services to customers. On occasion, Wagner did provide chiropractic services to customers of WCAC. However, he also submitted inflated bills to public and private health care beneficiary programs, including Medicare. Wagner charged those programs at the higher rates for services rendered by medical doctors, instead of the rates appropriate for chiropractors. In addition, Wagner systematically submitted claims for reimbursement for services not rendered.

As part of the fraud scheme, Wagner submitted fraudulent billings in the names of medical doctors. By doing so, the health care beneficiary programs would make payments directly to those medical doctors. The doctors accepted those payments and would often split the fraudulently obtained insurance payments with Wagner. In the case of at least one medical doctor participating in the fraudulent scheme, Wagner received payments from the health care beneficiary programs by check and then deposited those checks into the medical doctor’s bank account.

Wagner also provided customers of WCAC with prescriptions for prescription drugs, often in return for cash payments. Since he could not prescribe controlled substances, Wagner provided prescriptions for controlled substances to customers of WCAC using the names of medical doctors who were aware that Wagner was using their names illegally. Many of the patients who obtained prescriptions for controlled substances through Wagner used their Medicaid coverage at pharmacies to pay for those controlled substances.

This case was investigated by the Federal Bureau of Investigation, Food and Drug Administration, Department of Health and Human Services Office of Inspector General, Florida Department of Financial Services, Florida Department of Health, and the Florida Department of Law Enforcement. It is being prosecuted by Assistant United States Attorney Daniel C. Irick.

Monday, August 20, 2012

Local and Out of State Pain Clinic Owners and Doctors Charged in Prescription Drug Conspiracies


Federal Indictments Charge Several Pain Clinic Owners and Doctors with Making Millions by Illegally Distributing Prescription Drugs to Kentuckians

PIKEVILLE—Between today and late Thursday afternoon, five indictments have been unsealed charging 22 defendants, including five pain clinic owners and six doctors, with offenses related to prescription drugs, money laundering, and health care fraud.

One of the indictments alleges that Houston, Texas Doctor Linda J. Roos, 46, conspired to unlawfully distribute pills to Pike County residents.

Dr. Roos allegedly prescribed more than 125,000 Oxycodone pills from September 2006 until July 2011. She allegedly faxed many of her prescriptions to a pharmacy in Pikeville so the patients who visited her could pick up the pills on their way home from Texas. To limit traveling, Roos often allowed patients to obtain a prescription by faxing her a form.

Dennis and Helen Varney, patients of Dr. Roos, were charged with conspiracy to distribute prescription drugs. Authorities found hundreds of Oxycodone pills while searching the Varney’s residence. Dennis Varney, 62, is charged with multiple counts of distributing Oxycodone pills.

In a second indictment, a Pikeville pharmacy manager, Beverly Lockhart, 58, allegedly conspired with Pikeville Doctor Thad Manning, 46, to illegally sell prescription drug samples.

In the same indictment, Lockhart is charged with health care fraud conspiracy. She allegedly defrauded Medicare by submitting reimbursement claims for medications the pharmacy never provided to the customers.

Another indictment alleges that Tammy Cantrell, 39, and Shelby Lackey, 50, co-owners of Caremore pain clinic in Johnson County, conspired with a doctor to distribute Hydrocodone to Johnson County residents. They allegedly made nearly $2 million in drug proceeds.

A fourth indictment alleges that the co-owners of Auto Accident and Health Care in Auxier, Ky., Ray Douglas Stapleton, 34, and his wife Tina Marie Stapleton, 33, conspired with two doctors. They schemed to unlawfully dispense Oxycodone, Hydrocodone, and Xanax to Johnson County residents. The scheme made approximately $1.5 million from July 2010 through June 2012.

According to yet another indictment, Jody Robinson, 37, a pain clinic owner in Florida, conspired with a doctor to launder money and illegally dispense prescription drugs to patients from Boyd, Greenup, and Lawrence Counties. The clinic allegedly made approximately $2 million in just over a year.

Kerry B. Harvey, U.S. Attorney for the Eastern District of Kentucky; Perrye Turner, Special Agent in Charge, Federal Bureau of Investigation; Rodney Brewer, Kentucky State Police Commissioner; Antoinette V. Henry, U.S. Food and Drug Administration, Office of Criminal Investigations; Jack Conway, Kentucky Attorney General; Robert L. Corso, Special Agent in Charge, Drug Enforcement Administration; and Joe Williams, Director of Appalachia HIDTA, jointly announced the indictments.

The investigation was conducted by the FBI, KSP, Kentucky Attorney General’s Office, FDA, Kentucky Board of Pharmacy, DEA, Kentucky Board of Medical Licensure, and Kentucky Office of Inspector General, Drug Enforcement Branch. Assistant U.S. Attorneys Roger West and Lee Gentry presented the indictments to the grand jury.

The health care fraud, prescription drug, and money laundering conspiracies carry maximum penalties of 20 years in prison. However, the court must consider the U.S. Sentencing Guidelines and the applicable federal statutes before imposing any sentence following a conviction.

The indictment of a person by a grand jury is an accusation only, and that person is presumed innocent unless proven guilty.